SecBot SecBot
SECBOTREPLAY Home › Report › UTHR

UTHR · CEO Martine Rothblatt sold ~$5.9M of UTHR stock over two days (Sep…

UNITED THERAPEUTICS Corp · CLUSTER filed Sep 10, 2026 at 16:31 ET

At the news

MIXEDIMPACT 4/10

CLUSTER filed Sep 10, 2026 at 16:31 ET

CEO Martine Rothblatt sold ~$5.9M of UTHR stock over two days (Sep 8-9), including shares acquired via option exercises at $117.76, while EVP & General Counsel Paul Mahon sold $1.13M on Sep 3. The sales coincide with the company's announcement of a $477.6M accelerated share repurchase (ASR) agreement with Citibank on Sep 8. The CEO's large-scale selling alongside a major capital return program creates a mixed signal, the buyback is credit-positive and reduces share count, but insider sales of this magnitude by the top executive warrant caution. At ~0.03% of market cap, the total open-market sales are trivial in proportion, but the CEO's concentrated selling pattern is notable given her insider status and the proximity to the ASR announcement.

  • CEO Martine Rothblatt sold ~$5.9M in open-market sales over Sep 8-9, including shares from option exercises at $117.76 strike price.
  • EVP & General Counsel Paul Mahon sold $1.13M on Sep 3.
  • Company announced $477.6M accelerated share repurchase (ASR) agreement with Citibank on Sep 8, receiving ~719,376 initial shares.
  • Total open-market insider sales of ~$7.0M represent ~0.03% of UTHR's $21.7B market cap, trivial proportionally.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access